Nabriva Therapeutics to Present Data at ASM/ESCMID Conference Demonstrating Utility of Xenleta™ (lefamulin) for Patients with Community-Acquired Bacterial Pneumonia (CABP)

September 5, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search